Malkas and colleagues have documented a cancer-specific isoform of PCNA in breast cancer cells that interacts with DNA polymerase δ [5] They have developed a polyclonal antibody specific to this isoform, and they suggest this antibody may serve as a biomarker of breast cancer through histological staining. Here, PCNA is linked to breast carcinoma.